GL1X · GenesisL1 explorer

Research workbench

Fragment-based drug discovery targeting inhibitor of apoptosis proteins: compound 21

Analyse Fragment-based drug discovery targeting inhibitor of apoptosis proteins… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
5C83
Type
protein
Length
107 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
E3 ubiquitin-protein ligase xiap
EC
6.3.2.-
UniProt
P98170
Ligands
4YN, ZN

Structure

x-ray diffraction · 1 distinct chain · 48% helix, 7% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AE3 ubiquitin-protein ligase xiap (EC 6.3.2.-)protein10748% helix, 7% strandP98170

Ligands and binding sites

  • 4YN · (2R,5R)-4-[2-(6-benzyl-3,3-dimethyl-2,3-dihydro-1H-pyrrolo[3,2-c]pyridin-1-yl)-2-oxoethyl]-5-(methoxymethyl)-2-methylpiperazin-1-ium · ligand · chains A
  • ZN · Zinc ion · metal · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Compared structures

  • 5C83 · Fragment-Based Drug Discovery Targeting Inhibitor of Apoptosis Proteins: Compound 21 · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.